Piramal Pharma Limited (PPLPHARMA) — Capital Reinvestment Ratio
Latest as of September 2025:
0.49x
Piramal Pharma Limited (PPLPHARMA) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs8.90 Billion) in capital expenditures (Rs4.33 Billion). See Piramal Pharma Limited (PPLPHARMA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.49x
Capex / Operating Cash Flow
Operating Cash Flow
Rs8.90 Billion
INR
Capital Expenditures
Rs4.33 Billion
INR
Data as of
Sep 2025
Most recent filing
Piramal Pharma Limited Capital Reinvestment Ratio (2021–2026)
This chart tracks Piramal Pharma Limited's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Piramal Pharma Limited (2021–2026)
Year-by-year Capital Reinvestment Ratio for Piramal Pharma Limited from 2021 to 2026. For live market cap and broader valuation context, see market cap of Piramal Pharma Limited.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.64x | Rs14.00 Billion | Rs8.90 Billion | ▼ -14.6% |
| 2025 | 0.74x | Rs8.92 Billion | Rs6.64 Billion | ▲ +5.0% |
| 2024 | 0.71x | Rs10.05 Billion | Rs7.12 Billion | ▼ -64.4% |
| 2023 | 1.99x | Rs4.84 Billion | Rs9.65 Billion | ▲ +153.8% |
| 2022 | 0.79x | Rs2.55 Billion | Rs2.01 Billion | ▼ -53.1% |
| 2021 | 1.67x | Rs347.20 Million | Rs581.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow